Attached files

file filename
EX-10.7 - FORM OF PERFORMANCE UNIT AGREEMENT - AMGEN INCamgn-ex107_20161231x10k.htm
10-K - 10-K - AMGEN INCamgn-12312016x10k.htm
EX-32 - SECTION 1350 CERTIFICATIONS - AMGEN INCamgn-ex32_20161231x10k.htm
EX-31 - RULE 13A-14(A) CERTIFICATIONS - AMGEN INCamgn-ex31_20161231x10k.htm
EX-10.32 - AMENDMENT NO. 2 TO COLLABORATION AND LICENSE AGREEMENT - AMGEN INCamgn-ex1032_20161231x10k.htm
EX-10.20 - AGREEMENT BETWEEN AMGEN INC. AND MS. LORI A. JOHNSTON - AMGEN INCamgn-ex1020_20161231x10k.htm
EX-10.5 - FORM OF GLOBAL RSU AGREEMENT - AMGEN INCamgn-ex105_20161231x10k.htm
EX-10.4 - FORM OF STOCK OPTION AGREEMENT - AMGEN INCamgn-ex104_20161231x10k.htm
Exhibit 21

AMGEN INC.

The following is a list of subsidiaries of the Company as of December 31, 2016, omitting some subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary.    
 
 
STATE OR OTHER
SUBSIDIARY
 
JURISDICTION OF
(Name under which
 
INCORPORATION
subsidiary does business)
 
OR ORGANIZATION
 
 
 
Alantos Pharmaceuticals Holding, Inc.
 
Delaware
Amgen (Europe) GmbH
 
Switzerland
Amgen Fremont Inc.
 
Delaware
Amgen Global Finance B.V.
 
Netherlands
Amgen Holding No. 1
 
Bermuda
Amgen Manufacturing, Limited
 
Bermuda
Amgen Ilac Ticaret Limited Sirketi
 
Turkey
Amgen Research (Munich) GmbH
 
Germany
Amgen Rockville, Inc.
 
Delaware
Amgen SF, LLC
 
Delaware
Amgen Technology (Ireland)
 
Ireland
Amgen Technology, Limited
 
Bermuda
Amgen USA Inc.
 
Delaware
Amgen Worldwide Holdings B.V.
 
Netherlands
ATL Holdings Limited
 
Bermuda
ATL Holdings II Limited
 
Bermuda
BioVex, Inc.
 
Delaware
Immunex Corporation
 
Washington
Immunex Rhode Island Corporation
 
Delaware
Onyx Pharmaceuticals, Inc.
 
Delaware
Onyx Therapeutics, Inc.
 
Delaware


1